These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12842601)

  • 1. Novel alternative methods for the delivery of drugs for the treatment of asthma.
    Chan HK; Chew NY
    Adv Drug Deliv Rev; 2003 Jul; 55(7):793-805. PubMed ID: 12842601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of dry powder inhalers.
    Chougule MB; Padhi BK; Jinturkar KA; Misra A
    Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation therapy: technological milestones in asthma treatment.
    Dalby R; Suman J
    Adv Drug Deliv Rev; 2003 Jul; 55(7):779-91. PubMed ID: 12842600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of dry powder inhaler design, formulation, and performance.
    Newman SP; Busse WW
    Respir Med; 2002 May; 96(5):293-304. PubMed ID: 12113378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of particle morphology in pharmaceutical powder aerosols?
    Chan HK
    Expert Opin Drug Deliv; 2008 Aug; 5(8):909-14. PubMed ID: 18712999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1302-19. PubMed ID: 17455364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novolizer: the new technology for the management of asthma therapy.
    Köhler D
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP; Marriott C; Zeng XM
    Pharm Res; 2007 Feb; 24(2):361-9. PubMed ID: 17177114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of therapeutic response to antiasthma drugs: dry powder vs. conventional aerosol delivery systems.
    Saccar CL
    J Aerosol Med; 1996; 9(1):89-94. PubMed ID: 10160213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation therapy in asthmatic and not asthmatic children.
    Lo Valvo L; Leonardi S; Marseglia GL; Miraglia Del Giudice M; Salpietro C; Ciprandi G; La Rosa M
    Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):61-7. PubMed ID: 22032789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1282-301. PubMed ID: 17455324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM; Chan HK; Chiou H; Edge S; Tee TH; Traini D
    J Pharm Sci; 2007 May; 96(5):1331-41. PubMed ID: 17455362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    AAPS PharmSciTech; 2019 Jan; 20(3):94. PubMed ID: 30690674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
    Lucas P; Anderson K; Staniforth JN
    Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of insulin dry powder for inhalation.
    Mahesh Kumar T; Misra A
    Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.